Botanical species · safety record

Albizia lebbeck

The EFSA Compendium of Botanicals holds 18 constituent measurements and 2 adverse-effect records for Albizia lebbeck. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Albizia lebbeck (L.) Benth.

18Constituent measurements
2Safety records
9Cited sources
6Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Albizia lebbeck as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Bark
  • Bark extract
  • Stem bark

What the records describe

Constituents measured

  • Saponins4
  • Alkaloids3
  • Tannins2
  • Triterpene saponins2
  • Anthraquinone1
  • Calcium oxalate1
  • Epicatechin-3-gallate1
  • Epigallocatechin gallate1
  • Lectins1
  • Phenolic compounds1

Plant parts

  • Seed10
  • Leaves7
  • Bark2
  • Roots and other underground parts1

Preparations

  • Solvent extraction18

Effect types

  • Digestive2

Target tissues

  • Digestive2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsSeedSolvent extractionUnspecifiedResolve DOI
AnthraquinoneSeedSolvent extractionUnspecifiedResolve DOI
LectinsSeedSolvent extractionUnspecifiedResolve DOI
Phenolic compoundsSeedSolvent extractionUnspecifiedResolve DOI
SaponinsSeedSolvent extractionUnspecifiedResolve DOI
SaponinsSeedSolvent extractionUnspecifiedResolve DOI
SteroidsSeedSolvent extractionUnspecifiedResolve DOI
Triterpene saponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsLeavesSolvent extractionUnspecifiedNo resolvable identifier
AlkaloidsLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Calcium oxalateLeavesSolvent extractionUnspecifiedNo resolvable identifier
Epicatechin-3-gallateLeavesSolvent extraction0.0098 PercentUnspecifiedNo resolvable identifier
Epigallocatechin gallateLeavesSolvent extraction0.0183 PercentUnspecifiedNo resolvable identifier
SaponinsBarkSolvent extractionNo resolvable identifier
SaponinsLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
TanninsBarkSolvent extractionNo resolvable identifier
TanninsLeavesSolvent extractionUnspecifiedNo resolvable identifier
Triterpene saponinsSeedSolvent extractionNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveSeedGallus gallus (chicken) (as animal)SubchronicNo resolvable identifier
DigestiveDigestiveSeedGallus gallus (chicken) (as animal)SubchronicNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Amog, P. U., Manjuprasanna, V. N., Yariswamy, M., Urs, A. N. Nanjaraj., Joshi, Vikram., Suvilesh, K. N., Nataraju, A., Vishwanath, Bannikuppe Sannanaik., Gowda, T. V. Albizia lebbeck seed methanolic extract as a complementary therapy to manage local toxicity of Echis carinatus venom in a murine model . Pharmaceutical biology, 2016, vol. 54, no. 11, p. 2568-2574. DOI
  2. GALAL, M., BASHIR, AK., SALIH, AM., ADAM, SEI. ACTIVITY OF WATER EXTRACTS OF ALBIZZIA-ANTHELMINTICA AND A-LEBBEK BARKS AGAINST EXPERIMENTAL HYMENOLEPIS-DIMINUTA INFECTION IN RATS . Journal of ethnopharmacology, 1991, vol. 31, no. 3, p. 333-337. DOI
  3. Olorunsanya, A.O., Egbewande, O.O., Ibrahim, H., Adeyemo, M.M. Growth performance and carcass analysis of broiler chickens fed graded levels of toasted Albizia lebbeck seed meal. Pakistan journal of nutrition, 2010, vol. 9, no. 9, p. 873-876.
  4. Yadav, Shyamlal Singh., Galib., Prajapati, Pradeep Kumar., Rudrappa, Harisha C. Pharmacognostical and physicochemical investigations of Albizia lebbeck benth. leaf. International journal of science innovations and discoveries, 2011, vol. 1, no. 2, p. 178-185.
  5. Bobby, M. D. Nazneen., Wesely, E. G., Johnson, M. High performance thin layer chromatography profile studies on the alkaloids of Albizia lebbeck . Asian pacific journal of tropical biomedicine, 2012, vol. 2, no. Suppl. 1, p. S1-S6.
  6. SOTELO, A., CONTRERAS, E., FLORES, S. NUTRITIONAL-VALUE AND CONTENT OF ANTINUTRITIONAL COMPOUNDS AND TOXICS IN 10 WILD LEGUMES OF YUCATAN PENINSULA . Plant foods for human nutrition, 1995, vol. 47, no. 2, p. 115-123. DOI
  7. Kumar, D., Dash, G.K., Tripathy, N.K. Hypoglycaemic activity of bark extracts of Albizia lebbeck benth. in streptozotocin induced diabetic rats. International journal of pharmaceutical sciences review and research, 2013, vol. 18, no. 2, p. 28-32.
  8. Scott, Janelle P., Tinto, Winston F., Reynolds, William F. Triterpenoidal Saponins and Prosapogenins from Albizia lebbeck (Leguminosae) . Natural product communications, 2008, vol. 3, no. 11, p. 1763-1770.
  9. Note, Olivier Placide., Jihu, Dong., Antheaume, Cyril., Zeniou, Maria., Pegnyemb, Dieudonne Emmanuel., Guillaume, Dominique., Chneiwess, Herve., Kilhoffer, Marie Claude., Lobstein, Annelise. Triterpenoid saponins from Albizia lebbeck (L.) Benth and their inhibitory effect on the survival of high grade human brain tumor cells . Carbohydrate research, 2015, vol. 404, p. 26-33. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue